Publications 2025
CD4+FOXP3Exon2+ regulatory T cell frequency predicts breast cancer prognosis and survival.
Fusco C, Di Rella F, Liotti A, Colamatteo A, Ferrara AL, Gigantino V, Collina F, Esposito E, Donzelli I, Porcellini A, Feola A, Micillo T, Perna F, Garziano F, Maniscalco GT, Varricchi G, Mottola M, Zuccarelli B, De Simone B, di Bonito M, Matarese G, et al.
Sci Adv. 2025 Jan 17;11(3):eadr7934. doi: 10.1126/sciadv.adr7934